IDRA - イデラ・ファ―マシュ―ティカルズ (Idera Pharmaceuticals Inc.) イデラ・ファ―マシュ―ティカルズ

 IDRAのチャート


 IDRAの企業情報

symbol IDRA
会社名 Idera Pharmaceuticals Inc (イデラ・ファ―マシュ―ティカルズ)
分野(sector) Health Care   ヘルスケア
産業(industry) Biotechnology: Biological Products (No Diagnostic Substances)  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 イデラ・ファーマシューティカルズ(Idera Pharmaceuticals Inc.)は腫瘍学及び希少疾患の治療薬の発見・開発・商業化に焦点を当てた臨床段階のバイオ医薬企業である。同社はトール様受容体(TLR)ターゲティング技術および第3世代アンチセンス(3GA)技術を含む薬物候補を設計・開発するために、2つの創薬技術プラットフォームを利用する。TLR技術を使用して、同社は特定のTLRの活性を調節することによって作用する合成オリゴヌクレオチドに基づく薬物候補を設計する。3GA技術を用いて、病気を引き起こす遺伝子に関連するメッセンジャーリボ核酸(mRNA)をオフにする薬剤候補を開発する。同社の薬物候補には、IMO-8400、IMO-2125およびIMO-9200が含まれる。同社は、TLRアンタゴニストおよびアゴニストを、標的化TLRの活性を調節することによって作用させるように設計した。同社は病気を引き起こす遺伝子に関連するmRNAを消す3GA技術を開発する。   イデラ・ファ―マシュ―ティカルズは、臨床段階の米国バイオテクノロジ―企業。自己免疫疾患の治療のためと特定の遺伝的に定義されたフォ―ムのB細胞リンパ腫の治療製薬の開発に従事する。癌、感染症やアルツハイマ―病などの分野でTLR7、TLR8、およびTLR9作用薬を含むワクチンの製品を、研究・開発、商業化する。   
本社所在地 167 Sidney Street Cambridge MA 02139 USA
代表者氏名 James A. Geraghty ジェームズ・A.グラガッティ
代表者役職名 Independent Chairman of the Board
電話番号 +1 484-348-1600
設立年月日 32629
市場名 NASDAQ Small Cap
ipoyear ―年
従業員数
url www.iderapharma.com
nasdaq_url https://www.nasdaq.com/symbol/idra
adr_tso
EBITDA EBITDA(百万ドル) -65.52800
終値(lastsale) 8.71
時価総額(marketcap) 236684259.63
時価総額 時価総額(百万ドル) 191.30390
売上高 売上高(百万ドル) 0.75500
企業価値(EV) 企業価値(EV)(百万ドル) 97.25790
当期純利益 当期純利益(百万ドル) -65.58200
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Idera Pharmaceuticals Inc revenues decreased 26% to $418K. Net loss decreased 1% to $36.1M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Research and development decrease of 17% to $24.4M (expense) Interest income increase of 62% to $482K (income).

 IDRAのテクニカル分析


 IDRAのニュース

   Tesla Giga Press’ Major Advantages Recognized by JPMorgan, Could Further Disrupt Industry  2021/02/11 13:52:43 Tesmanian
JPMorgan met the Founder and CEO of LK Technology and the Head of IDRA to understand Tesla's drastic changes in vehicle production Thanks to Giga Press and its potential impact on the industry. After the meeting, JPMorgan made several key findings that indicate Tesla's clear superiority over other automakers.
   The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa  2021/01/22 12:22:33 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 21) Acasti Pharma Inc (NASDAQ: ACST ) Alimera Sciences Inc (NASDAQ: ALIM ) argenx SE – ADR (NASDAQ: ARGX ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) AzurRx BioPharma Inc (NASDAQ: AZRX ) Chimerix Inc (NASDAQ: CMRX ) Edap Tms SA (NASDAQ: EDAP ) Eli Lilly And Co (NYSE: LLY ) (announced positive results for its COVID-19 antibody treatment) ESSA Pharma Inc (NASDAQ: EPIX ) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Inari Medical Inc (NASDAQ: NARI ) INmune Bio Inc (NASDAQ: INMB ) ( INSM ) Integra Lifesciences Holdings Corp (NASDAQ: IART ) Inventiva ADR Representing Ord Shs (NASDAQ: IVA ) Jounce Therapeutics Inc (NASDAQ: JNCE ) Krystal Biotech Inc (NASDAQ: KRYS ) Laboratory Corp. of America Holdings (NYSE: LH ) Merus NV (NASDAQ: MRUS ) Neuronetics Inc (NASDAQ: STIM ) OncoSec Medical Inc (NASDAQ: ONCS ) (announced common stock offering) PRA Health Sciences Inc (NASDAQ: PRAH ) Precision BioSciences Inc (NASDAQ: DTIL ) Profound Medical Corp (NASDAQ: PROF ) Renalytix AI PLC (NASDAQ: RNLX ) Rhythm Pharmaceuticals Inc (NASDAQ: RYTM ) Seelos Therapeutics Inc (NASDAQ: SEEL ) Surface Oncology Inc (NASDAQ: SURF ) Syneos Health Inc (NASDAQ: SYNH ) Synlogic Inc (NASDAQ: SYBX ) Twist Bioscience Corp (NASDAQ: TWST ) Vericel Corp (NASDAQ: VCEL ) Xencor Inc (NASDAQ: XNCR ) Down In The Dumps None of the biotech/medical device/diagnostic stocks hit 52-week highs in the session.
   Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) CEO Sells $10,713.40 in Stock  2021/01/12 01:52:42 Watchlist News
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) CEO Vincent Milano sold 2,740 shares of the business’s stock in a transaction dated Tuesday, January 5th. The shares were sold at an average price of $3.91, for a total value of $10,713.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through […]
   The Year of the ‘Giga Press’: How Tesla’s monster machines can complete Elon Musk’s 2nd Master Plan  2020/12/20 16:16:02 Teslarati
One of the most exciting developments from Tesla eagerly awaited by the electric car community is the company’s use of its giant casting machines. Dubbed by its maker IDRA as the “Giga Press,” the house-sized monster machines are capable of producing single-cast pieces for Tesla’s vehicles, starting with the Model Y. The Giga Press lives […] The post The Year of the ‘Giga Press’: How Tesla’s monster machines can complete Elon Musk’s 2nd Master Plan appeared first on TESLARATI .
   Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Major Shareholder Invest Corp Pillar Buys 69,941 Shares  2020/12/16 11:22:44 Watchlist News
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) major shareholder Invest Corp Pillar bought 69,941 shares of Idera Pharmaceuticals stock in a transaction that occurred on Friday, December 11th. The stock was bought at an average cost of $1.82 per share, with a total value of $127,292.62. The acquisition was disclosed in a legal filing with the Securities & […]
   The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa  2021/01/22 12:22:33 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Jan. 21) Acasti Pharma Inc (NASDAQ: ACST ) Alimera Sciences Inc (NASDAQ: ALIM ) argenx SE – ADR (NASDAQ: ARGX ) Axonics Modulation Technologies Inc (NASDAQ: AXNX ) AzurRx BioPharma Inc (NASDAQ: AZRX ) Chimerix Inc (NASDAQ: CMRX ) Edap Tms SA (NASDAQ: EDAP ) Eli Lilly And Co (NYSE: LLY ) (announced positive results for its COVID-19 antibody treatment) ESSA Pharma Inc (NASDAQ: EPIX ) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Inari Medical Inc (NASDAQ: NARI ) INmune Bio Inc (NASDAQ: INMB ) ( INSM ) Integra Lifesciences Holdings Corp (NASDAQ: IART ) Inventiva ADR Representing Ord Shs (NASDAQ: IVA ) Jounce Therapeutics Inc (NASDAQ: JNCE ) Krystal Biotech Inc (NASDAQ: KRYS ) Laboratory Corp. of America Holdings (NYSE: LH ) Merus NV (NASDAQ: MRUS ) Neuronetics Inc (NASDAQ: STIM ) OncoSec Medical Inc (NASDAQ: ONCS ) (announced common stock offering) PRA Health Sciences Inc (NASDAQ: PRAH ) Precision BioSciences Inc (NASDAQ: DTIL ) Profound Medical Corp (NASDAQ: PROF ) Renalytix AI PLC (NASDAQ: RNLX ) Rhythm Pharmaceuticals Inc (NASDAQ: RYTM ) Seelos Therapeutics Inc (NASDAQ: SEEL ) Surface Oncology Inc (NASDAQ: SURF ) Syneos Health Inc (NASDAQ: SYNH ) Synlogic Inc (NASDAQ: SYBX ) Twist Bioscience Corp (NASDAQ: TWST ) Vericel Corp (NASDAQ: VCEL ) Xencor Inc (NASDAQ: XNCR ) Down In The Dumps None of the biotech/medical device/diagnostic stocks hit 52-week highs in the session.
   Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) CEO Sells $10,713.40 in Stock  2021/01/12 01:52:42 Watchlist News
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) CEO Vincent Milano sold 2,740 shares of the business’s stock in a transaction dated Tuesday, January 5th. The shares were sold at an average price of $3.91, for a total value of $10,713.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through […]
   The Year of the ‘Giga Press’: How Tesla’s monster machines can complete Elon Musk’s 2nd Master Plan  2020/12/20 16:16:02 Teslarati
One of the most exciting developments from Tesla eagerly awaited by the electric car community is the company’s use of its giant casting machines. Dubbed by its maker IDRA as the “Giga Press,” the house-sized monster machines are capable of producing single-cast pieces for Tesla’s vehicles, starting with the Model Y. The Giga Press lives […] The post The Year of the ‘Giga Press’: How Tesla’s monster machines can complete Elon Musk’s 2nd Master Plan appeared first on TESLARATI .
   Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) Major Shareholder Invest Corp Pillar Buys 69,941 Shares  2020/12/16 11:22:44 Watchlist News
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) major shareholder Invest Corp Pillar bought 69,941 shares of Idera Pharmaceuticals stock in a transaction that occurred on Friday, December 11th. The stock was bought at an average cost of $1.82 per share, with a total value of $127,292.62. The acquisition was disclosed in a legal filing with the Securities & […]
   The Daily Biotech Pulse: Lilly Secures Additional Orders For COVID-19 Antibody Treatment, Decision Day For BioCryst, Kinnate Biopharma To Make Wall Street Debut  2020/12/03 12:46:12 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Dec. 2) Amicus Therapeutics, Inc. (NASDAQ: FOLD ) Beam Therapeutics Inc (NASDAQ: BEAM ) Bioanalytical Systems, Inc. (NASDAQ: BASI ) Cerevel Therapeutics Holdings Inc (NASDAQ: CERE ) Fate Therapeutics Inc (NASDAQ: FATE ) Generation Bio Co (NASDAQ: GBIO ) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Infinity Pharmaceuticals Inc. (NASDAQ: INFI ) Inhibrx Inc (NASDAQ: INBX ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Iovance Biotherapeutics Inc (NASDAQ: IOVA ) Inspire Medical Systems Inc (NYSE: INSP ) Kymera Therapeutics Inc (NASDAQ: KYMR ) Larimar Therapeutics Inc (NASDAQ: LRMR ) Merrimack Pharmaceuticals Inc (NASDAQ: MACK ) (reacted to positive outlook for the cancer drug it sold to Ispen, which opens the possibility of realizing potential milestone payments) Myovant Sciences Ltd (NYSE: MYOV ) Ocular Therapeutix Inc (NASDAQ: OCUL ) Olema Pharmaceuticals Inc (NASDAQ: OLMA ) Oncorus Inc (NASDAQ: ONCR ) OncoSec Medical Inc (NASDAQ: ONCS ) Pfizer Inc. (NYSE: PFE ) ( announced U.K. regulatory nod for emergency use of its coronavirus vaccine candidate) Praxis Precision Medicines Inc (NASDAQ: PRAX ) Pulse Biosciences Inc (NASDAQ: PLSE ) Spero Therapeutics Inc (NASDAQ: SPRO ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Dec. 2) Histogen Inc (NASDAQ: HSTO ) Nabriva Therapeutics PLC – ADR (NASDAQ: NBRV ) (shares will trade …
   The Daily Biotech Pulse: Bluebird Bio Plunges On Regulatory Filing Delay, Synlogic Soars On Study Initiation, European Label Expansion For Vertex, Merck Goes Shopping  2020/11/05 12:54:15 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 4) Abbott Laboratories (NYSE: ABT ) Amicus Therapeutics, Inc. (NASDAQ: FOLD ) Anavex Life Sciences Corp (NASDAQ: AVXL ) Aptevo Therapeutics Inc (NASDAQ: APVO ) Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) Ascendis Pharma A/S (NASDAQ: ASND ) Athira Pharma Inc (NASDAQ: ATHA ) Bio-Rad Laboratories, Inc. Class A Common Stock (NYSE: BIO ) Bio-Rad Laboratories, Inc. Class B Common Stock (NYSE: BIO ) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN ) BioLife Solutions Inc (NASDAQ: BLFS ) Cardiff Oncology Inc (NASDAQ: CRDF ) Denali Therapeutics Inc (NASDAQ: DNLI ) - moved in sympathy with Biogen Inc (NASDAQ: BIIB ) Guardant Health Inc (NASDAQ: GH ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) Hologic, Inc. (NASDAQ: HOLX ) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Inspire Medical Systems Inc (NYSE: INSP ) Immunovant Inc (NASDAQ: IMVT ) Intellia Therapeutics Inc (NASDAQ: NTLA ) Jazz Pharmaceuticals PLC (NASDAQ: JAZZ ) Kodiak Sciences Inc (NASDAQ: KOD ) Laboratory Corp.
   The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings  2020/11/04 13:21:27 Benzinga
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Nov. 3) Bio-Rad Laboratories, Inc. (NYSE: BIO ) Biohaven Pharmaceutical Holding Co Ltd (NYSE: BHVN ) BioLife Solutions Inc (NASDAQ: BLFS ) BioLineRx ADR Representing 15 Ord Shs (NASDAQ: BLRX )(reacted to positive readout for its stem cell therapy to treat cancer) Halozyme Therapeutics, Inc. (NASDAQ: HALO )(reacted to its quarterly results) Idera Pharmaceuticals Inc (NASDAQ: IDRA ) Inspire Medical Systems Inc (NYSE: INSP ) ( reported strong results for the third quarter) Immunovant Inc (NASDAQ: IMVT ) Scholar Rock Holding Corp (NASDAQ: SRRK ) Ultragenyx Pharmaceutical Inc (NASDAQ: RARE ) United Therapeutics Corporation (NASDAQ: UTHR ) Down In The Dumps (Biotech Stocks Hitting 52-week Lows Nov. 3) Abeona Therapeutics Inc (NASDAQ: ABEO ) Aprea Therapeutics Inc (NASDAQ: APRE ) Bellicum Pharmaceuticals Inc (NASDAQ: BLCM ) Benitec Biopharma Inc (NASDAQ: BNTC ) Esperion Therapeutics Inc (NASDAQ: ESPR ) (reacted to its quarterly results) Happiness Biotech Group Ltd (NASDAQ: HAPP ) Jaguar Health Inc (NASDAQ: JAGX ) Liminal BioSciences Inc (NASDAQ: LMNL ) Nabriva Therapeutics PLC – ADR (NASDAQ: NBRV ) Neovasc Inc (NASDAQ: NVCN ) Opthea Spon (NASDAQ: OPT ) Silence Therapeutics ADR (NASDAQ: SLN ) Titan Pharmaceuticals, Inc (NASDAQ: TTNP ) Stocks In Focus Bristol-Myers Squibb Says Antitrust Waiting Period For Proposed Myokardia Acquisition Expires Bristol-Myers Squibb Co (NYSE: BMY ) said the waiting period under the HSR Act in connection with its previously announced tender offer to acquire …
   Idera Pharmaceuticals (NASDAQ:IDRA) Stock Crosses Above 200 Day Moving Average of $1.98  2020/10/22 02:40:50 US Banking News
Idera Pharmaceuticals, Inc. (NASDAQ:IDRA) passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $1.98 and traded as high as $2.17. Idera Pharmaceuticals shares last traded at $2.09, with a volume of 166,014 shares changing hands. Several equities research analysts recently commented on the company. HC […]
   Idera Pharmaceuticals Reports Second Quarter Financial Results and Provides Corporate Update  2020/08/04 20:10:00 GlobeNewswire
Enhanced Financial Flexibility as ILLUMINATE-301 Continues on Track
   Idera Pharmaceuticals Inc (IDRA): Hedge Funds Are Nibbling On  2020/06/22 03:13:49 Yahoo Finance
In this article we will check out the progression of hedge fund sentiment towards Idera Pharmaceuticals Inc (NASDAQ:IDRA) and determine whether it is a good investment right now. We at Insider Monkey like to examine what billionaires and hedge funds think of a company before spending days of research

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 イデラ・ファ―マシュ―ティカルズ IDRA Idera Pharmaceuticals Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)